AT-6 Papaverine 40 mg/mL Phentolamine 4 mg/mL Atropine 0 recalled over sterility concerns
- Recall date
- May 9, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Olympia Compounding Pharmacy dba Olympia Pharmacy recalls AT-6 Papaverine 40 mg/mL Phentolamine 4 mg/mL Atropine 0.3 mg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceutica…
- Recall number
- D-0919-2022
- FDA classification
- Class II
- Brand / firm
- Olympia Compounding Pharmacy dba Olympia Pharmacy
- Sold / distributed
- Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands
Why it was recalled
Lack of assurance of sterility.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
AT-6 Papaverine 40 mg/mL Phentolamine 4 mg/mL Atropine 0.3 mg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835 NDC 73198-0040-10
Get recall alerts
Free email alert whenever Olympia Compounding Pharmacy dba Olympia Pharmacy has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Olympia Compounding Pharmacy dba Olympia Pharmacy